These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 26169618)

  • 1. Stable Peptide of the Endogenous Opioid Enkephalin Precursor and Breast Cancer Risk.
    Melander O; Orho-Melander M; Manjer J; Svensson T; Almgren P; Nilsson PM; Engström G; Hedblad B; Borgquist S; Hartmann O; Struck J; Bergmann A; Belting M
    J Clin Oncol; 2015 Aug; 33(24):2632-8. PubMed ID: 26169618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High Level of Fasting Plasma Proenkephalin-A Predicts Deterioration of Kidney Function and Incidence of CKD.
    Schulz CA; Christensson A; Ericson U; Almgren P; Hindy G; Nilsson PM; Struck J; Bergmann A; Melander O; Orho-Melander M
    J Am Soc Nephrol; 2017 Jan; 28(1):291-303. PubMed ID: 27401687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of plasma proneurotensin as a novel biomarker for the prediction of incident breast cancer.
    Melander O; Belting M; Manjer J; Maisel AS; Hedblad B; Engström G; Nilsson P; Struck J; Hartmann O; Bergmann A; Orho-Melander M
    Cancer Epidemiol Biomarkers Prev; 2014 Aug; 23(8):1672-6. PubMed ID: 24925674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma proneurotensin and incidence of diabetes, cardiovascular disease, breast cancer, and mortality.
    Melander O; Maisel AS; Almgren P; Manjer J; Belting M; Hedblad B; Engström G; Kilger U; Nilsson P; Bergmann A; Orho-Melander M
    JAMA; 2012 Oct; 308(14):1469-75. PubMed ID: 23047361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proenkephalin predicts acute kidney injury in cardiac surgery patients.
    Shah KS; Taub P; Patel M; Rehfeldt M; Struck J; Clopton P; Mehta RL; Maisel AS
    Clin Nephrol; 2015 Jan; 83(1):29-35. PubMed ID: 25512100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating insulin-like growth factor-I and binding protein-3 and the risk of breast cancer.
    Baglietto L; English DR; Hopper JL; Morris HA; Tilley WD; Giles GG
    Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):763-8. PubMed ID: 17416768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer.
    Krajcik RA; Borofsky ND; Massardo S; Orentreich N
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1566-73. PubMed ID: 12496045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fasting glucose is a risk factor for breast cancer: a prospective study.
    Muti P; Quattrin T; Grant BJ; Krogh V; Micheli A; Schünemann HJ; Ram M; Freudenheim JL; Sieri S; Trevisan M; Berrino F
    Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1361-8. PubMed ID: 12433712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Correlates and Prognostic Value of Proenkephalin in Acute and Chronic Heart Failure.
    Matsue Y; Ter Maaten JM; Struck J; Metra M; O'Connor CM; Ponikowski P; Teerlink JR; Cotter G; Davison B; Cleland JG; Givertz MM; Bloomfield DM; Dittrich HC; van Veldhuisen DJ; van der Meer P; Damman K; Voors AA
    J Card Fail; 2017 Mar; 23(3):231-239. PubMed ID: 27663098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.
    Tworoger SS; Missmer SA; Barbieri RL; Willett WC; Colditz GA; Hankinson SE
    J Natl Cancer Inst; 2005 Apr; 97(8):595-602. PubMed ID: 15840882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proenkephalin and risk of developing chronic kidney disease: the Prevention of Renal and Vascular End-stage Disease study.
    Kieneker LM; Hartmann O; Bergmann A; de Boer RA; Gansevoort RT; Joosten MM; Struck J; Bakker SJL
    Biomarkers; 2018 Jul; 23(5):474-482. PubMed ID: 29466891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Copeptin, a marker of vasopressin, in abdominal obesity, diabetes and microalbuminuria: the prospective Malmö Diet and Cancer Study cardiovascular cohort.
    Enhörning S; Bankir L; Bouby N; Struck J; Hedblad B; Persson M; Morgenthaler NG; Nilsson PM; Melander O
    Int J Obes (Lond); 2013 Apr; 37(4):598-603. PubMed ID: 22614056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC).
    Kaaks R; Berrino F; Key T; Rinaldi S; Dossus L; Biessy C; Secreto G; Amiano P; Bingham S; Boeing H; Bueno de Mesquita HB; Chang-Claude J; Clavel-Chapelon F; Fournier A; van Gils CH; Gonzalez CA; Gurrea AB; Critselis E; Khaw KT; Krogh V; Lahmann PH; Nagel G; Olsen A; Onland-Moret NC; Overvad K; Palli D; Panico S; Peeters P; Quirós JR; Roddam A; Thiebaut A; Tjønneland A; Chirlaque MD; Trichopoulou A; Trichopoulos D; Tumino R; Vineis P; Norat T; Ferrari P; Slimani N; Riboli E
    J Natl Cancer Inst; 2005 May; 97(10):755-65. PubMed ID: 15900045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma Proenkephalin and Poor Long-Term Outcome in Renal Transplant Recipients.
    Kieneker LM; Hartmann O; Struck J; Bergmann A; Gansevoort RT; Joosten MM; van den Berg E; de Boer RA; Bakker SJL
    Transplant Direct; 2017 Aug; 3(8):e190. PubMed ID: 28795142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary fat and postmenopausal invasive breast cancer in the National Institutes of Health-AARP Diet and Health Study cohort.
    Thiébaut AC; Kipnis V; Chang SC; Subar AF; Thompson FE; Rosenberg PS; Hollenbeck AR; Leitzmann M; Schatzkin A
    J Natl Cancer Inst; 2007 Mar; 99(6):451-62. PubMed ID: 17374835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma natriuretic peptides and incidence of subtypes of ischemic stroke.
    Berntsson J; Zia E; Borné Y; Melander O; Hedblad B; Engström G
    Cerebrovasc Dis; 2014; 37(6):444-50. PubMed ID: 25060145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Energy balance and breast cancer risk: a prospective cohort study.
    Silvera SA; Jain M; Howe GR; Miller AB; Rohan TE
    Breast Cancer Res Treat; 2006 May; 97(1):97-106. PubMed ID: 16319973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective study of leukocyte count as a predictor of incident breast, colorectal, endometrial, and lung cancer and mortality in postmenopausal women.
    Margolis KL; Rodabough RJ; Thomson CA; Lopez AM; McTiernan A;
    Arch Intern Med; 2007 Sep; 167(17):1837-44. PubMed ID: 17893304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Precursor fractions of neurotensin and enkephalin might point to molecular mechanisms of cancer risk modulation during a lifestyle-intervention in germline BRCA1/2 gene mutation carriers.
    Grill S; Yahiaoui-Doktor M; Basrai M; Struck J; Schulte J; Berling-Ernst A; Engel C; Ullrich M; Lammert J; Bischoff SC; Schmidt T; Niederberger U; Chronas D; Rhiem K; Schmutzler R; Halle M; Kiechle M
    Breast Cancer Res Treat; 2021 Apr; 186(3):741-752. PubMed ID: 33543354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasoactive peptides with angiogenesis-regulating activity predict cancer risk in males.
    Belting M; Almgren P; Manjer J; Hedblad B; Struck J; Wang TJ; Bergmann A; Melander O
    Cancer Epidemiol Biomarkers Prev; 2012 Mar; 21(3):513-22. PubMed ID: 22267286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.